Reducing from 1 mg to 0.5 mg, or from 2 mg to 1 mg, is a perfectly valid approach
How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test may help provide context for how your genetic predispositions in GLP-1 receptor, glucose-dependent insulinotropic peptide, and weight-regulation pathways relate to your likelihood of response and side-effect tolerance
A new systematic review published in the journal eClinicalMedicine on Wednesday examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications such as liraglutide (under brand names such as Victoza and Saxenda), semaglutide (under brand names such as Ozempic, Wegovy, Rybelsus) and tirzepatide (under brand names like Mounjaro and Zepbound)
The easy-to-swallow capsules make supplementation hassle-free, allowing you to focus on what matters most: your performance
New England Journal of Medicine 376, 15171526
